06/02/2026
The Sickle Cell Federation of Kenya is hosting a two-day meeting (5th–6th February 2026) to strengthen its governance structures through the induction of newly selected Scientific, Research, and Patient Advocacy Committees.
As SFK prepares for the next five-year strategic period, CEO Emily Gumba shared key milestones achieved so far and reaffirmed the Federation’s mission to champion the welfare of people living with sickle cell disease.
Key highlights from the engagement:
• Participation of key partners and stakeholders, including Mr. Llyord Mwaniki from Novo Nordisk Haemophilia & Haemoglobinopathies Foundation, Mr. Abdoulsalaam from Fondation Pierre Fabre, and Dr. Gladwell Gathecha from The Ministry of Health, underscoring the importance of coordinated national action.
• Strong focus on governance strengthening, with emphasis on the role of committees in strategy, accountability, and implementation
• Commitment to building systems that position SFK as a leading patient organization in Africa, with calls for sustained investment in long-term impact.
• Recognition of SFK as a key stakeholder within the national health ecosystem, and the importance of alignment with Ministry of Health policies and guidelines.
• Emphasis on evidence-based advocacy, with data guiding priorities, decision-making, and national engagement
Overall, the meeting underscored the need for unified leadership, stronger coordination with partners, and empowered committees to drive governance, advocacy, and program delivery.
With continued support from donors and the Ministry of Health, SFK remains committed to championing evidence-based action, stronger health systems, and improved access to quality care for people living with sickle cell disease.